{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:14:59Z","timestamp":1772050499029,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xops.2024.100634","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:45:08Z","timestamp":1729514708000},"page":"100634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Shoko","family":"Kondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iraha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-6828","authenticated-orcid":false,"given":"Shoji","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2024.100634_bib1","series-title":"International Textbook of Leprosy","year":"2016"},{"key":"10.1016\/j.xops.2024.100634_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12886-023-03146-2","article-title":"Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study","volume":"23","author":"Irawati","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/eye.2011.43","article-title":"The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years","volume":"25","author":"Malik","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.xops.2024.100634_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12886-022-02265-6","article-title":"Bilateral corneal perforation caused by neurotrophic keratopathy associated with leprosy: a case report","volume":"22","author":"Iraha","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jtos.2020.09.007","article-title":"The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. A review","volume":"19","author":"Ruiz-Lozano","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.xops.2024.100634_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jtos.2023.09.001","article-title":"Neurotrophic keratopathy: an updated understanding","volume":"30","author":"Cheung","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.xops.2024.100634_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8","article-title":"Synergistic effects of substance P with insulin-like growth factor 1 on epithelial migration of the cornea","volume":"169","author":"Nishida","year":"1996","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.xops.2024.100634_bib9","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1167\/iovs.05-1205","article-title":"Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1","volume":"47","author":"Yamada","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100634_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archopht.1997.01100160096021","article-title":"Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1","volume":"115","author":"Brown","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(98)24024-4","article-title":"Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I","volume":"351","author":"Chikama","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2024.100634_bib12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(99)04198-7","article-title":"Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy","volume":"354","author":"Morishige","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2024.100634_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10384-007-0480-z","article-title":"Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P-derived peptide and insulin-like growth factor 1","volume":"51","author":"Nishida","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bjo.2007.130013","article-title":"Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy","volume":"92","author":"Yamada","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.preteyeres.2015.01.004","article-title":"Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions","volume":"47","author":"Nishida","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2024.100634_bib16","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sachetti","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo.75.2.117","article-title":"Corneal sensitivity and correlations between decreased sensitivity and anterior segment pathology in ocular leprosy","volume":"75","author":"Kara\u00e7orlu","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib19","first-page":"51","article-title":"State of ocular sequelae and visual dysfunction in individuals with Hansen's disease","volume":"123","author":"Shigeyasu","year":"2019","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.xops.2024.100634_bib20","series-title":"Current ocular therapy","first-page":"452","article-title":"Neuroparalytic keratitis","author":"Mackie","year":"1995"},{"key":"10.1016\/j.xops.2024.100634_bib21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archopht.121.11.1537","article-title":"A\u00a0novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability","volume":"121","author":"Miyata","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10384-009-0693-4","article-title":"Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients","volume":"53","author":"Chikamoto","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100634_bib23","first-page":"C1482","article-title":"Substance P promotes TGF-\u03b2-induced collagen synthesis in human corneal fibroblasts","volume":"326","author":"Sugioka","year":"2024","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.xops.2024.100634_bib24","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1002\/jcp.27345","article-title":"In\u00a0vivo microscopic and optical coherence tomography classification of neurotrophic keratopathy","volume":"234","author":"Mastropasqua","year":"2019","journal-title":"J\u00a0Cell Physiol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:46:09Z","timestamp":1772048769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914524001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666914524001702"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2024.100634","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2024.100634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100634"}}